By Jacob M. Thompson “The FDA remains concerned about the increasing prevalence of xylazine mixed with illicit drugs, and this action is one part…
By Jacob M. Thompson “The FDA remains concerned about the increasing prevalence of xylazine mixed with illicit drugs, and this action is one part…